Taylor Wealth Management Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,164
Closed -$412K 69
2021
Q4
$412K Sell
25,164
-41,804
-62% -$872K 0.15% 49
2021
Q3
$1.95M Buy
66,968
+686
+1% +$22.8K 0.69% 43
2021
Q2
$2.3M Sell
66,282
-1,223
-2% -$38.8K 0.81% 43
2021
Q1
$2.13M Sell
67,505
-1,045
-2% -$42.5K 0.78% 43
2020
Q4
$3.24M Sell
68,550
-301
-0.4% -$14K 1.25% 31
2020
Q3
$3.21M Buy
68,851
+226
+0.3% +$7.76K 1.47% 28
2020
Q2
$2.48M Sell
68,625
-6,886
-9% -$254K 1.26% 30
2020
Q1
$2.68M Sell
75,511
-3,850
-5% -$158K 1.64% 24
2019
Q4
$3.61M Sell
79,361
-470
-0.6% -$17.1K 1.66% 23
2019
Q3
$1.98M Sell
79,831
-295
-0.4% -$7.39K 0.93% 28
2019
Q2
$1.76M Buy
+80,126
New +$1.47M 0.82% 28

Other funds holding ZYME

Taylor Wealth Management Partners's ZYME Position: Q1 2022 in Review

Taylor Wealth Management Partners sold out of Zymeworks (ZYME) in Q1 2022, closing a stake of 25,164 shares — an estimated $412K sold.

Taylor Wealth Management Partners first reported a position in ZYME in Q2 2019 and held it in 11 quarters. The position peaked at $3.61M in Q4 2019. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

  • Taylor Wealth Management Partners reported no remaining Zymeworks position as of Q1 2022 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 25,164 Zymeworks shares in Q1 2022, an estimated $412K.
  • Taylor Wealth Management Partners first reported a position in Zymeworks in Q2 2019 and held it in 11 quarters.
  • Taylor Wealth Management Partners's Zymeworks position peaked at $3.61M in Q4 2019.
  • 120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q1 2022, filed 11 May 2022.